20 May 2019 in Nature Communications
Substrates associate and products dissociate from enzyme catalytic sites rapidly, which hampers investigations of their trajectories. The high-resolution structure of the native Hordeum exo-hydrolase HvExoI isolated from seedlings reveals that non-covalently trapped glucose forms a stable enzyme-product complex. Here, we report that the alkyl β-d-glucoside and methyl 6-thio-β-gentiobioside substrate analogues perfused in crystalline HvExoI bind across the catalytic site after they displace glucose, while methyl 2-thio-β-sophoroside attaches nearby. Structural analyses and multi-scale molecular modelling of nanoscale reactant movements in HvExoI reveal that upon productive binding of incoming substrates, the glucose product modifies its binding patterns and evokes the formation of a transient lateral cavity, which serves as a conduit for glucose departure to allow for the next catalytic round. This path enables substrate-product assisted processive catalysis through multiple hydrolytic events without HvExoI losing contact with oligo- or polymeric substrates. We anticipate that such enzyme plasticity could be prevalent among exo-hydrolases.
3 September 2026 in Nature Communications
Most antipsychotic drugs (APDs) cause hyperphagia and weight gain, yet the neural mechanisms underlying these metabolic side effects remain elusive, in part due to difficulties in modeling them in rodents. Here, we establish a mouse model that recapitulates clozapine-induced metabolic syndrome, enabling mechanistic investigation of this widely prescribed APD. We show that clozapine promotes obesity in female mice by driving hyperphagia, which requires functional coupling between the melanocortin 4 receptor (MC4R) and the Kir7.1 potassium channel. Within the broader context of clozapine’s polypharmacology, this signaling axis emerges as a critical downstream convergence node for APD-induced metabolic dysfunction. Mechanistically, clozapine inhibits MC4R-expressing neurons in the paraventricular nucleus of the hypothalamus by enhancing MC4R-Kir7.1 coupling, thereby increasing inward potassium currents. Notably, clozapine produces this inhibition without binding the MC4R orthosteric site and without engaging canonical Gαs signaling. Genetic deletion of Kir7.1 in MC4R neurons or pharmacological inhibition of Kir7.1 reverses clozapine-induced weight gain while preserving its behavioral efficacy in established antipsychotic assays. Together, these findings reveal a G-protein-independent mechanism by which clozapine disrupts energy balance and identify MC4R-Kir7.1 coupling as a therapeutically tractable pathway for mitigating APD-associated metabolic dysfunction.
27 July 2026 in Nature Communications
Hereditary defects in the function of the inwardly rectifying potassium channel Kir7.1 in the retinal pigment epithelium are associated with the ocular diseases retinitis pigmentosa, Leber congenital amaurosis, and snowflake vitreoretinal degeneration. However, this ion channel is widely expressed, and studies also suggest that Kir7.1 may be directly regulated in a G protein-independent manner by a GPCR, the melanocortin-4 receptor (MC4R), in specific hypothalamic neurons involved in energy homeostasis. To advance our understanding of this unusual direct regulation of an ion channel by a GPCR, it is important to characterize the structure and function of Kir7.1, and the Kir7.1-MC4R complex. Utilizing cryo-electron microscopy, we present structures of human Kir7.1 and demonstrate the structural basis for the blockade of the channel by a small molecule ML418. We show that channel blockade of Kir7.1 depolarizes MC4R neurons in a slice preparation of the paraventricular nucleus of the hypothalamus (PVH), and activates PVH neurons in vivo, inhibiting food intake and inducing weight loss. We further show that Kir7.1 and MC4R are in close association on the plasma membrane and characterize a fusion construct of MC4R and Kir7.1 that provides an experimental tool for study of Kir7.1 regulation by the MC4R.